COMMUNIQUÉS West-GlobeNewswire
-
Nordic Naturals Joins Eudēmonia Summit as Featured Partner and Exhibitor, Hosting Panel on Omega-3s and Healthy Aging
28/10/2026 -
Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call
28/10/2026 -
Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026
28/10/2026 -
MIMEDX Announces $25 Million Patent License Agreement
28/10/2026 -
ARS Pharma to Report Third Quarter 2026 Financial Results
28/10/2026 -
Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis
28/10/2026 -
MIMEDX Announces Third Quarter 2026 Operating & Financial Results
28/10/2026 -
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
28/10/2026 -
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
28/10/2026 -
Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026
28/10/2026 -
Teladoc Health Reports Third Quarter 2026 Results
28/10/2026 -
Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology
28/10/2026 -
Jushi Holdings Inc. Reports Third Quarter 2026 Financial Results
28/10/2026 -
Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026
28/10/2026 -
BayCare Selected as a National Best Workplace for Women
28/10/2026 -
NVision Unveils First Manufacturable Molecular Qubit, Breakthrough Validated in Peer-Reviewed Nature Paper
28/10/2026 -
RYBREVANT®▼ (amivantamab) sous-cutané affiche un taux de réponse objective de 77 pour cent en traitement de première ligne chez des patients atteints de certaines formes avancées de cancer de la tête et du cou
28/10/2026 -
Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis
28/10/2026 -
Curabotics Enters National Contract with Capstone Health Alliance, Bringing Robotics and Automation to Hundreds of Hospitals
28/10/2026
Pages